Targeted Oncology

eISSN: 1776-260XpISSN: 1776-2596

Journal formatting to fit the target journal guidelines

Experts ensure all elements of your paper match journal formatting guidelines to improve publication success rate!

Key Metrics

CiteScore
7.2
Impact Factor
5 - 10
SJR
Q2Oncology
SNIP
1.03

Journal Specifications

Overview
  • Publisher
    SPRINGER
  • Language
    English
  • Frequency
    Bi-monthly
General Details
View less

Ready to spotlight your research findings?

Impress peers and journals alike with a concise, visual summary of your work.

Meets Top Publisher Standards: Essential for leading journals like Elsevier.
Enhances Engagement: Research papers with graphical abstracts receive 3X more downloads and 8X more shares.
Tailored Just for You: We’ll create a custom graphical abstract based on your manuscript—no sketches needed.
Learn more 3000+ graphical abstracts produced with 4.8/5 customer rating

Topics Covered

Epidermal growth factor receptor
Lung cancer
P53 expression
Progression-free survival
Breast cancer
Hepatocellular carcinoma
Crizotinib
Copanlisib
Overall survival
Pembrolizumab
Confidence interval
Adenocarcinoma
Objective response
Colorectal cancer
Mutation testing
Cerebrospinal fluid
Immunotherapy
Metastatic breast cancer
Melanoma
Erlotinib

Recently Published Papers

Year-wise Publication

FAQs

Since when has Targeted Oncology been publishing? Faqs

The Targeted Oncology has been publishing since 2006 till date.

How frequently is the Targeted Oncology published? Faqs

Targeted Oncology is published Bi-monthly.

Who is the publisher of Targeted Oncology? Faqs

The publisher of Targeted Oncology is SPRINGER.

How can I view the journal metrics of Targeted Oncology on editage? Faqs

For the Targeted Oncology metrics, please refer to the section above on the page.

What is the eISSN and pISSN number of Targeted Oncology? Faqs

The eISSN number is 1776-260X and pISSN number is 1776-2596 for Targeted Oncology.

What is the focus of this journal? Faqs

The journal covers a wide range of topics inlcuding Epidermal growth factor receptor, Lung cancer, P53 expression, Progression-free survival, Breast cancer, Hepatocellular carcinoma, Crizotinib, Copanlisib, Overall survival, Pembrolizumab, Confidence interval, Adenocarcinoma, Objective response, Colorectal cancer, Mutation testing, Cerebrospinal fluid, Immunotherapy, Metastatic breast cancer, Melanoma, Erlotinib.

Why is it important to find the right journal for my research? Faqs

Choosing the right journal ensures that your research reaches the most relevant audience, thereby maximizing its scholarly impact and contribution to the field.

Can the choice of journal affect my academic career? Faqs

Absolutely. Publishing in reputable journals can enhance your academic profile, making you more competitive for grants, tenure, and other professional opportunities.

Is it advisable to target high-impact journals only? Faqs

While high-impact journals offer greater visibility, they are often highly competitive. It's essential to balance the journal's impact factor with the likelihood of your work being accepted.